A possible role of nuclear ceramide and sphingosine in hepatocyte apoptosis in rat liver

Journal of Hepatology

Volumn 31, Issue 1, 1999, Pages 8-17

  Tsugane, Kyoji ^a   Tamiya Koizumi, Keiko ^b   Nagino, Masato ^a   Nimura, Yuji ^a   Yoshida, Shonen ^b  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Res Inst Dis Mechanism and Contr   (Japan)

Author keywords

Apoptosis; Ceramidase; Ceramide; Neutral sphingomyelinase; Portal vein branch ligation; Rat liver; Sphingomyelin; Sphingosine

Indexed keywords

ACYLSPHINGOSINE DEACYLASE; CELL DNA; CERAMIDE; DNA FRAGMENT; SPHINGOMYELIN; SPHINGOMYELIN PHOSPHODIESTERASE; SPHINGOSINE;

ANIMAL EXPERIMENT; APOPTOSIS; ARTICLE; CONTROLLED STUDY; DEGRADATION; DISEASE COURSE; DNA DETERMINATION; DNA STRAND BREAKAGE; ENZYME ACTIVITY; HUMAN TISSUE; LIPOLYSIS; LIVER HISTOLOGY; MALE; NONHUMAN; PORTAL VEIN OBSTRUCTION; PRIORITY JOURNAL; RAT;

EID: 0032996374     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-8278(99)80158-5     Document Type: Article

References (59)

1. Makuuchi M, Thai BL, Takayasu K, Takayama T, Kosuge T, Gunven P, et al. Preoperative portal embolization to increase safety of major hepatectomy for hilar bile duct carcinoma: a preliminary report. Surgery. 107:1990;521-527.
2. Kinoshita H, Sakai K, Hirohashi K, Igawa S, Yamasaki O, Kubo S. Preoperative portal vein embolization for hepatocellular carcinoma. World J Surg. 10:1986;803-808.
3. Nagino M, Nimura Y, Hayakawa N. Percutaneous transhepatic portal embolization using newly devised catheters: preliminary report. World J Surg. 17:1993;520-524.
4. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Right or left trisegment portal vein embolization before hepatic trisegmentectomy for hilar bile duct carcinoma. Surgery. 117:1995;677-681.
5. Nagino M, Nimura Y, Kamiya J, Kondo S, Uesaka K, Kin Y, et al. Changes in hepatic lobe volume in biliary tract cancer patients after right portal vein embolization. Hepatology. 21:1995;434-439.
6. Nagino M, Nimura Y, Kamiya J, Kondo S, Kanai M. Selective percutaneous transhepatic embolization of the portal vein in preparation for extensive liver resection: the ipsilateral approach. Radiology. 200:1996;559-563.
7. Ishihara H, Tamiya-Koizumi K, Kuriki H, Yoshida S, Kojima K. Growth-associated changes in fatty acid compositions of nuclear phospholipids of liver cells. Biochim Biophys Acta. 1084:1991;53-59.
8. Kuriki H, Tamiya-Koizumi K, Asano M, Yoshida S, Kojima K, Nimura Y. Existence of phosphoinositide-specific phospholipase C in rat liver nuclei and its change during liver regeneration. J Biochem. 111:1992;283-286.
9. Asano M, Tamiya-Koizumi K, Homma Y, Takenawa T, Nimura Y, Kojima K, et al. Purification and characterization of nuclear phospholipase C specific for phosphoinositides. J Biol Chem. 269:1994;12360-12366.
10. Takeuchi E, Nimura Y, Mizuno S, Suzuki H, Iyomasa S, Terasaki M, et al. Research review: DNA polymerases as molecular markers of the regenerating capacity of hepatocytes. J Hep Bil Pancr Surg. 4:1997;254-262.
11. Mizuno S, Nimura Y, Suzuki H, Yoshida S. Portal vein branch occlusion induces cell proliferation of cholestatic rat liver. J Surg Res. 60:1996;249-257.
12. Takeuchi E, Nimura Y, Mizuno S, Nagino M, Shoji-Kawaguchi M, Izuta S, et al. Ligation of portal vein branch induces DNA polymerases alpha, delta, and epsilon in non-ligated lobes. J Surg Res. 65:1996;15-24.
13. Kerr JF, Wyllie AH, Currie AR. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br J Cancer. 26:1972;239-257.
14. Rozga J, Jeppsson B, Bengmark S. Portal branch ligation in the rat. Reevaluation of a model. Am J Pathol. 125:1986;300-308.
15. Ikeda K, Kinoshita H, Hirohashi K, Kubo S, Kaneda K. The ultrastructure, kinetics and intralobular distribution of apoptotic hepatocytes after portal branch ligation with special reference to their relationship to necrotic hepatocytes. Arch Histol Cytol. 58:1995;171-184.
16. Harada H, Imamura H, Miyagawa S, Kawasaki S. Fate of the human liver after hemihepatic portal vein embolization: cell kinetic and morphometric study. Hepatology. 26:1997;1162-1170.
17. Kolesnick R, Golde DW. The sphingomyelin pathway in tumor necrosis factor and interleukin-1 signaling. Cell. 77:1994;325-328.
18. Hannun YA, Obeid LM. Ceramide: an intracellular signal for apoptosis. Trends Biochem Sci. 20:1995;73-77.
19. Spiegel S, Milstien S. Sphingolipid metabolites: members of a new class of lipid second messengers. J Membrane Biol. 146:1995;225-237.
20. Testi R. Sphingomyelin breakdown and cell fate. Trends Biochem Sci. 21:1996;468-471.
21. Ohta H, Yatomi Y, Sweeney EA, Hakomori S, Igarashi Y. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett. 355:1994;267-270.
22. Ohta H, Sweeney EA, Masamune A, Yatomi Y, Hakomori S, Igarashi Y. Induction of apoptosis by sphingosine in human leukemic HL-60 cells: a possible endogenous modulator of apoptotic DNA fragmentation occurring during phorbol ester-induced differentiation. Cancer Res. 55:1995;691-697.
23. Hung WC, Chuang LY. Induction of apoptosis by sphingosine-1-phosphate in human hepatoma cells is associated with enhanced expression of bax gene product. Biochem Biophys Res Commun. 229:1996;11-15.
24. Wiegmann K, Schutze S, Machleidt T, Witte D, Kronke M. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling. Cell. 78:1994;1005-1015.
25. Coroneos E, Martinez M, McKenna S, Kester M. Differential regulation of sphingomyelinase and ceramidase activities by growth factors and cytokines. Implications for cellular proliferation and differentiation. J Biol Chem. 270:1995;23305-23309.
26. Olivera A, Spiegel S. Sphingosine-1-phosphate as second messenger in cell proliferation induced by PDGF and FCS mitogens. Nature. 365:1993;557-560.
27. Tamiya-Koizumi K, Murate T, Suzuki M, Simbulan CM, Nakagawa M, Takemura M, et al. Inhibition of DNA primase by sphingosine and its analogues parallels with their growth suppression of cultured human leukemic cells. Biochem Mol Biol Int. 41:1997;1179-1189.
28. Spangler M, Coetzee ML, Katyal SL, Morris HP, Ove P. Some biochemical characteristics of rat liver and Morris hepatoma nuclei and nuclear membranes. Cancer Res. 35:1975;3131-3135.
29. Cocco L, Maraldi NM, Manzoli FA, Gilmour RS, Lang A. Phospholipid interactions in rat liver nuclear matrix. Biochem Biophys Res Commun. 96:1980;890-898.
30. Alesenko AV, Burlakova EB, Pantaz EA. Effect of sphingomyelin on RNA-polymerase activity in the cell nucleus of normal and regenerating rat liver. Biokhimiia. 49:1984;621-628.
31. Albi E, Magni MP. Chromatin neutral sphingomyelinase and its role in hepatic regeneration. Biochem Biophys Res Commun. 236:1997;29-33.
32. 2+-dependent, neutral sphingomyelinase in nuclei of rat ascites hepatoma cells. J Biochem. 106:1989;593-598.
33. Alessenko A, Chatterjee S. Neutral sphingomyelinase: localization in rat liver nuclei and involvement in regeneration/proliferation. Mol Cell Biochem. 143:1995;169-174.
34. Steiner PE, Martinez JB. Effects on rat liver of bile duct, portal vein and hepatic artery ligations. Am J Pathol. 39:1961;257-289.
35. Takiya S, Tagaya T, Takahashi K, Kawashima H, Kamiya M, Fukuzawa Y, et al. Role of transforming growth factor beta 1 on hepatic regeneration and apoptosis in liver diseases. J Clin Pathol. 48:1995;1093-1097.
36. Smith CA, Williams GT, Kingston R, Jenkinson EJ, Owen JJ. Antibodies to CD3/T-cell receptor complex induce death by apoptosis in immature T cells in thymic cultures. Nature. 337:1989;181-184.
37. Koizumi K, Ito Y, Kojima K, Fujii T. Isolation and characterization of the plasma membranes from rat ascites hepatomas and from normal rat livers, including newborn, regenerating, and adult livers. J Biochem. 79:1976;739-748.
38. Koizumi K, Tamiya-Koizumi K, Fujii T, Okuda J, Kojima K. Comparative study of the phospholipid composition of plasma membranes isolated from rat primary hepatomas induced by 3′-methyl-4-dimethylaminoazobenzene and from normal growing rat livers. Cancer Res. 40:1980;909-913.
39. 2+ dependency by polyphosphoinositides. Biochim Biophis Acta. 1052:1989;182-188.
40. Yavin E, Gatt S. Enzymatic hydrolysis of sphingolipids. 8. Further purification and properties of rat brain ceramidase. Biochemistry. 8:1969;1692-1698.
41. Sugita M, Williams M, Dulaney JT, Moser HW. Ceramidase and ceramide synthesis in human kidney and cerebellum. Biochim Biophys Acta. 398:1975;125-131.
42. Folch J, Lees M, Sloane Stanley GH. A simple method for isolation and purification of total lipides from animal tissues. J Biol Chem. 226:1957;497-509.
43. Merrill A Jr., Wang E, Mullins RE, Jamison WC, Nimkar S, Liotta DC. Quantitation of free sphingosine in liver by high-performance liquid chromatography. Anal Biochem. 171:1988;373-381.
44. Haimovitz-Friedman A, Kan CC, Ehleiter D, Persaud RS, McLoughlin M, Fuks Z, et al. Ionizing radiation acts on cellular membranes to generate ceramide and initiate apoptosis. J Exp Med. 180:1994;525-535.
45. Hannun YA, Bell RM. Functions of sphingolipids and sphingolipid breakdown products in cellular regulation. Science. 243:1989;500-507.
46. Hannun YA, Linardic CM. Sphingolipid breakdown products: anti-proliferative and tumor-suppressor lipids. Biochim Biophys Acta. 1154:1993;223-226.
47. Obeid LM, Linardic CM, Karolak LA, Hannun YA. Programmed cell death induced by ceramide. Science. 259:1993;1769-1771.
48. Simbulan CM, Tamiya-Koizumi K, Suzuki M, Shoji M, Taki T, Yoshida S. Sphingosine inhibits the synthesis of RNA primers by primasein vitro. Biochemistry. 33:1994;9007-9012.
49. Jefferson AB, Schulman H. Sphingosine inhibits calmodulin-de-pendent enzymes. J Biol Chem. 263:1988;15241-15244.
50. Arnold RS, Newton AC. Inhibition of the insulin receptor tyrosine kinase by sphingosine. Biochemistry. 30:1991;7747-7754.
51. Buckley AR, Crowe PD, Russell DH. Rapid activation of protein kinase C in isolated rat liver nuclei by prolactin, a known hepatic mitogen. Proc Nat Acad Sci USA. 85:1988;8649-8653.
52. Kinnunen PK, Rytomaa M, Koiv A, Lehtonen J, Mustonen P, Aro A. Sphingosine-mediated membrane association of DNA and its reversal by phosphatidic acid. Chem Phys Lipids. 66:1993;75-85.
53. Koiv A, Mustonen P, Kinnunen PK. Differential scanning calorimetry study on the binding of nucleic acids to dimyristoylphos-phatidylcholine-sphingosine liposomes. Chem Phys Lipids. 70:1994;1-10.
54. Koiv A, Kinnunen PK. Binding of DNA to liposomes containing different derivatives of sphingosine. Chem Phys Lipids. 72:1994;77-86.
55. Ghirlando R, Wachtel EJ, Arad T, Minsky A. DNA packaging induced by micellar aggregates: a novelin vitro DNA condensation system. Biochemistry. 31:1992;7110-7119.
56. 2+ dependency by polyphosphoinositides. Biochim Biophys Acta. 1002:1989;182-188.
57. 2 in rat ascites hepatoma cells. FEBS Lett. 394:1996;55-60.
58. Jayadev S, Linardic CM, Hannun YA. Identification of arachidonic acid as a mediator of sphingomyelin hydrolysis in response to tumor necrosis factor alpha. J Biol Chem. 269:1994;5757-5763.
59. 2 is necessary for tumor necrosis factor alpha-induced ceramide generation in L929 cells. J Biol Chem. 272:1997;17196-17203.